217 related articles for article (PubMed ID: 36160835)
21. Multiparametric Magnetic Resonance Imaging for the Diagnosis and Differential Diagnosis of Parotid Gland Tumors.
Gökçe E
J Magn Reson Imaging; 2020 Jul; 52(1):11-32. PubMed ID: 32065489
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
[TBL] [Abstract][Full Text] [Related]
23. The diagnostic value of combining conventional, diffusion-weighted imaging and dynamic contrast-enhanced MRI for salivary gland tumors.
Zheng N; Li R; Liu W; Shao S; Jiang S
Br J Radiol; 2018 Sep; 91(1089):20170707. PubMed ID: 29902075
[TBL] [Abstract][Full Text] [Related]
24. Value of diffusion tensor imaging in differentiating malignant from benign parotid gland tumors.
Takumi K; Fukukura Y; Hakamada H; Ideue J; Kumagae Y; Yoshiura T
Eur J Radiol; 2017 Oct; 95():249-256. PubMed ID: 28987676
[TBL] [Abstract][Full Text] [Related]
25. Perfusion Computed Tomography Scan Imaging in Differentiation of Benign from Malignant Parotid Lesions.
Niazi M; Mohammadzadeh M; Aghazadeh K; Sharifian H; Karimi E; Shakiba M; Baniasadi M; Rahmaty B; Adel S; Moharreri M
Int Arch Otorhinolaryngol; 2020 Apr; 24(2):e160-e169. PubMed ID: 32256836
[No Abstract] [Full Text] [Related]
26. A review of 413 salivary gland tumours in the head and neck region.
Lawal AO; Adisa AO; Kolude B; Adeyemi BF; Olajide MA
J Clin Exp Dent; 2013 Dec; 5(5):e218-22. PubMed ID: 24455085
[TBL] [Abstract][Full Text] [Related]
27. Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging in the differential diagnosis of parotid tumors.
Xiang S; Ren J; Xia Z; Yuan Y; Tao X
BMC Med Imaging; 2021 Dec; 21(1):194. PubMed ID: 34920706
[TBL] [Abstract][Full Text] [Related]
28. Tumor blood flow and apparent diffusion coefficient histogram analysis for differentiating malignant salivary tumors from pleomorphic adenomas and Warthin's tumors.
Tanaka F; Umino M; Maeda M; Nakayama R; Inoue K; Kogue R; Obara M; Sakuma H
Sci Rep; 2022 Apr; 12(1):5947. PubMed ID: 35396374
[TBL] [Abstract][Full Text] [Related]
29. The role of diffusion-weighted and dynamic contrast enhancement perfusion-weighted imaging in the evaluation of salivary glands neoplasms.
Pietragalla M; Nardi C; Bonasera L; Mungai F; Taverna C; Novelli L; De Renzis AGD; Calistri L; Tomei M; Occhipinti M; Colagrande S
Radiol Med; 2020 Sep; 125(9):851-863. PubMed ID: 32266692
[TBL] [Abstract][Full Text] [Related]
30. Intravoxel Incoherent Motion Magnetic Resonance Imaging for Assessing Parotid Gland Tumors: Correlation and Comparison with Arterial Spin Labeling Imaging.
Ma G; Xu XQ; Zhu LN; Jiang JS; Su GY; Hu H; Bu SS; Wu FY
Korean J Radiol; 2021 Feb; 22(2):243-252. PubMed ID: 32932565
[TBL] [Abstract][Full Text] [Related]
31. Application of Diffusion Kurtosis Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Differentiating Benign and Malignant Head and Neck Lesions.
Cheng J; Shao S; Chen W; Zheng N
J Magn Reson Imaging; 2022 Feb; 55(2):414-423. PubMed ID: 34378259
[TBL] [Abstract][Full Text] [Related]
32. Salivary gland tumors at in vivo proton MR spectroscopy.
King AD; Yeung DK; Ahuja AT; Tse GM; Yuen HY; Wong KT; van Hasselt AC
Radiology; 2005 Nov; 237(2):563-9. PubMed ID: 16244265
[TBL] [Abstract][Full Text] [Related]
33. Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and malignant soft tissue tumors.
Lee SK; Jee WH; Jung CK; Chung YG
Br J Radiol; 2020 Nov; 93(1115):20191035. PubMed ID: 32649224
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of diffusion-weighted MR imaging for differentiating between Warthin's tumor and oncocytoma of the parotid gland.
Kato H; Fujimoto K; Matsuo M; Mizuta K; Aoki M
Jpn J Radiol; 2017 Feb; 35(2):78-85. PubMed ID: 28074380
[TBL] [Abstract][Full Text] [Related]
35. Warthin's tumor of parotid gland: Surgery or follow-up? Diagnostic value of a decisional algorithm with functional MRI.
Espinoza S; Felter A; Malinvaud D; Badoual C; Chatellier G; Siauve N; Halimi P
Diagn Interv Imaging; 2016 Jan; 97(1):37-43. PubMed ID: 25543869
[TBL] [Abstract][Full Text] [Related]
36. Value of quantitative multiparametric MRI in differentiating pleomorphic adenomas from malignant epithelial tumors in lacrimal gland.
Wang Y; Song L; Guo J; Xian J
Neuroradiology; 2020 Sep; 62(9):1141-1147. PubMed ID: 32430642
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of salivary gland tumor using diffusion-weighted imaging with a fractional order calculus model.
Chen W; Zhu LN; Dai YM; Jiang JS; Bu SS; Xu XQ; Wu FY
Br J Radiol; 2020 Sep; 93(1113):20200052. PubMed ID: 32649236
[TBL] [Abstract][Full Text] [Related]
38. Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors.
Sumi M; Van Cauteren M; Sumi T; Obara M; Ichikawa Y; Nakamura T
Radiology; 2012 Jun; 263(3):770-7. PubMed ID: 22447854
[TBL] [Abstract][Full Text] [Related]
39. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland.
Liu YJ; Lee YH; Chang HC; Chung HW; Wang CW; Juan CH; Chu YH; Lee JC; Juan CJ
NMR Biomed; 2020 May; 33(5):e4282. PubMed ID: 32124504
[TBL] [Abstract][Full Text] [Related]
40. Histogram analysis of apparent diffusion coefficient maps for differentiating malignant from benign parotid gland tumors.
Ma G; Zhu LN; Su GY; Hu H; Qian W; Bu SS; Xu XQ; Wu FY
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2151-2157. PubMed ID: 29961924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
